MAPT and Alzheimer disease: Moreover, tau deposition has been observed to exhibit a more consistent and robust association with cognitive decline throughout aging and the AD spectrum (Nelson et al., 2012; Brier et al., 2016; Ossenkoppele et al., 2020), compared to amyloid deposition.